Sign in to continue:

Friday, July 31st, 2026

Day: May 20, 2026

Monopar Therapeutics Presents Positive Phase 2 Results for ALXN1840 in Wilson Disease Patients

Monopar Therapeutics Announces Positive Phase 2 Study Result...

BestGofer Inc. Files Form 8-K Announcing Non-Reliance on Previous Financial Statements (May 2026)

BestGofer, Inc. Issues Non-Reliance Notice on Q1 2026 Financ...